Recent Updates
Recently added Catalysts
JNJ Positive Sentiment

Johnson & Johnson to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Monday, August 10, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Johnson & Johnson will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026. The management team will engage in a Fireside Chat at 11:30 a.m. ET. Investors can access a live audio webcast of the presentation on the company's Investor Relations website, with an archived version available later.

Market Sentiment Analysis

POSITIVE FACTORS

  • Johnson & Johnson is actively engaging in investor relations.
  • Participation in a prominent healthcare conference highlights JNJ's commitment to transparency.
  • The event provides an opportunity for investors to gain insights from management.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Tapentadol
Phase 1 · Healthy

Full Press Release Details

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14th, 2026. Management will participate in a Fireside Chat at 11:30 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast replay will

Frequently Asked Questions

When will Johnson & Johnson present at the conference?

Johnson & Johnson will present at the Morgan Stanley conference on September 14, 2026.

What time is the Fireside Chat scheduled?

The Fireside Chat is scheduled for 11:30 a.m. Eastern Time.

Where can I access the live webcast?

The live audio webcast can be accessed on Johnson & Johnson's Investor Relations website.

Will there be a replay of the presentation?

Yes, an archived edition of the session will be available later that day.

ShareAdd on Google
Tags: JNJ Viatris Investor Conferences Healthcare Johnson & Johnson Morgan Stanley healthcare conference investor relations
Last updated: Aug 10, 2026

Biotech snapshot

Cash runway
$20758M liquidity · $0M/mo burn
Low dilution risk
Lead asset
TapentadolPhase 1
Healthy →

Catalyst track record

+34%
best trade around JNJ's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for JNJ.

See every catalyst's timing & PoA →